Chanda Siddoo-Atwal, B.Sc., Ph.D, Post-Doctoral Fellow, is the President and Primary Biochemist of Moondust Cosmetics Ltd
Chanda Siddoo-Atwal, completed her B.Sc. in Biochemistry from the University of London. Her Ph.D. was taken in Applied Sciences from Simon Fraser University in Burnaby (her research conducted at the BC Cancer Research Centre) and she did a Post-doctoral fellowship in the Biochemistry Department at the Medical College of Wisconsin.
Cancer is her subject of specialization and started with research on Ataxia-telangiectasia (AT) patients, who are genetically prone to lymphomas. Since then, she has focussed mainly on mechanisms of carcinogenesis in various models including the AT disease state and ionizing radiation-induced cancer, mycotoxin-induced and chemically-induced cancers, microwave-induced cancers, and ultraviolet radiation-induced skin cancer.
She is the President and Primary Biochemist of Moondust Cosmetics Ltd. and her current research activity includes the formulation of a novel sunscreen to combat apoptotic sunburn that has been associated with skin cancer and other suncare products for the repair of skin damage related to sun exposure.
She has been invited to present her research papers at conferences around the world and is the author of a recent book called, “A New Approach to Cancer Risk Assessment: An Overview” published by Lambert Academic Publishing. In addition, she has been asked to contribute chapters to textbooks by various international publishers including Springer and INTECH.
Recently, she received a Drishti Award in recognition of her scientific contribution and commitment to education in the sunscreen industry. She also has a Facebook page where she presents her research in a popular way to the public (www.facebook.com/DrMoondust/).
